TriSalus Life Sciences

About:

TriSalus Life Sciences develops novel infusion systems for the interventional radiology market.

Website: https://trisaluslifesci.com/

Twitter/X: SurefireMedical

Top Investors: OrbiMed, ORI Capital, Tullis Health Investors, Partisan Management Group, MCG Capital

Description:

TriSalus Life Sciences, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The company's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, which collapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue.

Total Funding Amount:

$126M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Westminster, Colorado, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)surefiremedical.com

Founders:

Aravind Arepally, James E. Chomas

Number of Employees:

11-50

Last Funding Date:

2024-04-30

IPO Status:

Public

Industries:

© 2025 bioDAO.ai